Search Results - "MacGuill, M."

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Delayed Treatment of Delirium Increases Mortality Rate in Intensive Care Unit Patients by Heymann, A, Radtke, F, Schiemann, A, Lütz, A, MacGuill, M, Wernecke, KD, Spies, C

    Published in Journal of international medical research (01-09-2010)
    “…Delirium in the intensive care unit (ICU) is a serious complication associated with a poor outcome in critically ill patients. In this prospective…”
    Get full text
    Journal Article
  2. 2

    Replacement of aprotinin by ε-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome by Martin, K, Gertler, R, MacGuill, M, Mayr, N P, Hapfelmeier, A, Hörer, J, Vogt, M, Tassani, P, Wiesner, G

    Published in British journal of anaesthesia : BJA (01-04-2013)
    “…Once aprotinin was no longer available for clinical use, ε-aminocaproic acid (EACA) and tranexamic acid became the only two options for antifibrinolytic…”
    Get full text
    Journal Article
  3. 3

    Switch from aprotinin to ε-aminocaproic acid: impact on blood loss, transfusion, and clinical outcome in neonates undergoing cardiac surgery by MARTIN, K, GERTLER, R, LIERMANN, H, MAYR, N. P, MACGUILL, M, SCHREIBER, C, VOGT, M, TASSANI, P, WIESNER, G

    Published in British journal of anaesthesia : BJA (01-12-2011)
    “…With the withdrawal of aprotinin from worldwide marketing in November 2007, many institutions treating patients at high risk for hyperfibrinolysis had to…”
    Get full text
    Journal Article
  4. 4

    Replacement of aprotinin by ɛ-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome by Martin, K., Gertler, R., MacGuill, M., Mayr, N.P., Hapfelmeier, A., Hörer, J., Vogt, M., Tassani, P., Wiesner, G.

    Published in British journal of anaesthesia : BJA (01-04-2013)
    “…Once aprotinin was no longer available for clinical use, ɛ-aminocaproic acid (EACA) and tranexamic acid became the only two options for antifibrinolytic…”
    Get full text
    Journal Article
  5. 5

    Comparison of blood-sparing efficacy of ε-aminocaproic acid and tranexamic acid in newborns undergoing cardiac surgery by Martin, K, Gertler, R, Sterner, A, MacGuill, M, Schreiber, C, Hörer, J, Vogt, M, Tassani, P, Wiesner, G

    Published in The Thoracic and cardiovascular surgeon (01-08-2011)
    “…ε-Aminocaproic acid (EACA) and tranexamic acid (TXA) are used for antifibrinolytic therapy in neonates undergoing cardiac surgery, although data directly…”
    Get more information
    Journal Article
  6. 6

    Hyperactive Delirium and Blood Glucose Control in Critically Ill Patients by Heymann, A, Sander, M, Krahne, D, Deja, M, Weber-Carstens, S, MacGuill, M, Kastrup, M, Wernecke, KD, Nachtigall, I, Spies, CD

    Published in Journal of international medical research (01-09-2007)
    “…Delirium is a common complication of critically ill patients and is often associated with metabolic disorders. One of the most frequent metabolic disorders in…”
    Get full text
    Journal Article
  7. 7

    Motivation of trauma patients to stop smoking after admission to the emergency department by Weiss-Gerlach, E, Franck, M, Neuner, B, Gentilello, L.M, Neumann, T, Tønnesen, H, Kolbeck, S, Cammann, H, Perka, C, MacGuill, M, Spies, C.D

    Published in Addictive behaviors (01-07-2008)
    “…Abstract Every smoker should be offered smoking cessation treatment when they present for clinical care. The Readiness to Change-Smokers (RTC-S) questionnaire…”
    Get full text
    Journal Article
  8. 8

    Clinicopathologic factors predicting complete pathological response to neoadjuvant chemoradiotherapy in esophageal cancer by MacGuill, M., Mulligan, E., Ravi, N., Rowley, S., Byrne, P. J., Hollywood, D., Kennedy, J., Keeling, P. N., Reynolds, J. V.

    Published in Diseases of the esophagus (01-08-2006)
    “…Multimodal therapy comprising neoadjuvant chemotherapy and radiation therapy prior to radical resection is increasingly utilized in gastroesophageal cancer…”
    Get full text
    Journal Article
  9. 9

    Switch from aprotinin to ɛ-aminocaproic acid: impact on blood loss, transfusion, and clinical outcome in neonates undergoing cardiac surgery by Martin, K., Gertler, R., Liermann, H., Mayr, N.P., MacGuill, M., Schreiber, C., Vogt, M., Tassani, P., Wiesner, G.

    Published in British journal of anaesthesia : BJA (01-12-2011)
    “…With the withdrawal of aprotinin from worldwide marketing in November 2007, many institutions treating patients at high risk for hyperfibrinolysis had to…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Seizures After Open Heart Surgery: Comparison of ε-Aminocaproic Acid and Tranexamic Acid by Martin, Klaus, MD, Knorr, Jürgen, MD, Breuer, Tamás, MD, Gertler, Ralph, MD, MacGuill, Martin, MD, Lange, Rüdiger, PhD, Tassani, Peter, PhD, Wiesner, Gunther, PhD

    “…Objective Although the lysine analogs tranexamic acid (TXA) and aminocaproic acid (EACA) are used widely for antifibrinolytic therapy in cardiac surgery,…”
    Get full text
    Journal Article